GPCR · Structure Therapeutics Inc. American Depositary Shares
View on chartInsiders & Stakes
| FMR LLC | ▼ Sell | Other | 4,769,404 Shares held | 2/7/2023 | View profile |
| Ramy Farid President & CEO | ▼ Sell | Other | 3,260,495 Shares held | 2/7/2023 | View profile |
| Jun Yoon CHIEF FINANCIAL OFFICER | ▲ Buy | Grant | 1,401,656 Shares held | 3/19/2026 | View profile |
| Raymond C. Stevens CHIEF EXECUTIVE OFFICER | ▲ Buy | Grant | 1,401,593 Shares held | 3/19/2026 | View profile |
| FIL Ltd | ▼ Sell | Other | 624,239 Shares held | 2/7/2023 | View profile |
| Crespo Blas Coll CHIEF MEDICAL OFFICER | ▼ Sell | Other | 258,228 Shares held | 9/21/2026 | View profile |
| Xichen Lin CHIEF SCIENTIFIC OFFICER | ▼ Sell | Other | 228,960 Shares held | 9/1/2026 | View profile |
| Matthew Lang Chief Business Officer | ▲ Buy | Grant | 184,614 Shares held | 4/15/2026 | View profile |
| Ashley Hall Chief Development Officer | ▲ Buy | Grant | 155,187 Shares held | 3/19/2026 | View profile |
| John Joseph Berrios Chief Commercial Officer | ▲ Buy | Grant | 140,766 Shares held | 8/6/2026 | View profile |
| Yingli Ma CHIEF TECHNOLOGY OFFICER | ▲ Buy | Grant | 139,917 Shares held | 3/19/2026 | View profile |
| Daniel G. Welch Director | ▼ Sell | Other | 123,508 Shares held | 2/7/2023 | View profile |
| Bach Mark Allen CHIEF MEDICAL OFFICER | ▲ Buy | Grant | 26,235 Shares held | 3/15/2024 | View profile |
| BVF PARTNERS L P/IL 10% Owner | ▼ Sell | Other | 0 Shares held | 5/10/2023 | View profile |
Transaction History
| Crespo Blas Coll | ▼ Sell | Other | 12,024 | $0 | 9/21/2026 |
| Crespo Blas Coll | ▼ Sell | Tax Withholding | 10,626 | $124K | 9/18/2026 |
| Xichen Lin | ▲ Buy | Option Exercise | 17,817 | $6K | 9/1/2026 |
| Xichen Lin | ▼ Sell | Other | 17,817 | $0 | 9/1/2026 |
| Xichen Lin | ▲ Buy | Option Exercise | 11,817 | $4K | 8/18/2026 |
| Xichen Lin | ▼ Sell | Other | 11,817 | $0 | 8/18/2026 |
| John Joseph Berrios | ▲ Buy | Grant | 140,766 | $0 | 8/6/2026 |
| Xichen Lin | ▲ Buy | Option Exercise | 11,817 | $4K | 8/4/2026 |
| Xichen Lin | ▼ Sell | Other | 11,817 | $0 | 8/4/2026 |
| Xichen Lin | ▲ Buy | Option Exercise | 23,634 | $8K | 7/14/2026 |
| Xichen Lin | ▼ Sell | Other | 23,634 | $0 | 7/14/2026 |
| Xichen Lin | ▲ Buy | Option Exercise | 23,634 | $8K | 6/25/2026 |
| Xichen Lin | ▼ Sell | Other | 23,634 | $0 | 6/25/2026 |
| Matthew Lang | ▲ Buy | Grant | 184,614 | $0 | 4/15/2026 |
| Ashley Hall | ▲ Buy | Grant | 47,706 | $0 | 3/19/2026 |
| Crespo Blas Coll | ▲ Buy | Grant | 75,897 | $0 | 3/19/2026 |
| Yingli Ma | ▲ Buy | Grant | 32,526 | $0 | 3/19/2026 |
| Xichen Lin | ▲ Buy | Grant | 43,368 | $0 | 3/19/2026 |
| Jun Yoon | ▲ Buy | Grant | 104,085 | $0 | 3/19/2026 |
| Raymond C. Stevens | ▲ Buy | Grant | 260,217 | $0 | 3/19/2026 |
| Crespo Blas Coll | ▼ Sell | Tax Withholding | 11,826 | $248K | 3/3/2026 |
| Yingli Ma | ▼ Sell | Tax Withholding | 11,313 | $237K | 3/3/2026 |
| Xichen Lin | ▼ Sell | Tax Withholding | 18,735 | $393K | 3/3/2026 |
| Jun Yoon | ▼ Sell | Tax Withholding | 22,305 | $468K | 3/3/2026 |
| Ashley Hall | ▼ Sell | Tax Withholding | 4,836 | $102K | 3/3/2026 |
| Raymond C. Stevens | ▼ Sell | Tax Withholding | 53,454 | $1.1M | 3/3/2026 |
| Ashley Hall | ▼ Sell | Tax Withholding | 6,021 | $47K | 9/18/2025 |
| Crespo Blas Coll | ▼ Sell | Tax Withholding | 8,106 | $63K | 9/18/2025 |
| Yingli Ma | ▼ Sell | Tax Withholding | 4,470 | $31K | 7/1/2025 |
| Xichen Lin | ▼ Sell | Tax Withholding | 12,846 | $88K | 7/1/2025 |
| Crespo Blas Coll | ▲ Buy | Grant | 7,992 | $0 | 7/1/2025 |
| Crespo Blas Coll | ▼ Sell | Tax Withholding | 1,434 | $10K | 7/1/2025 |
| Yingli Ma | ▲ Buy | Grant | 24,459 | $0 | 7/1/2025 |
| Xichen Lin | ▲ Buy | Grant | 57,078 | $0 | 7/1/2025 |
| Jun Yoon | ▲ Buy | Grant | 39,606 | $0 | 7/1/2025 |
| Jun Yoon | ▼ Sell | Tax Withholding | 7,089 | $48K | 7/1/2025 |
| Raymond C. Stevens | ▲ Buy | Grant | 89,697 | $0 | 7/1/2025 |
| Raymond C. Stevens | ▼ Sell | Tax Withholding | 16,050 | $110K | 7/1/2025 |
| Crespo Blas Coll | ▲ Buy | Grant | 116,988 | $0 | 3/15/2025 |
| Ashley Hall | ▲ Buy | Grant | 51,048 | $0 | 3/15/2025 |
| Yingli Ma | ▲ Buy | Grant | 63,810 | $0 | 3/15/2025 |
| Xichen Lin | ▲ Buy | Grant | 80,829 | $0 | 3/15/2025 |
| Jun Yoon | ▲ Buy | Grant | 170,166 | $0 | 3/15/2025 |
| Raymond C. Stevens | ▲ Buy | Grant | 340,332 | $0 | 3/15/2025 |
| Crespo Blas Coll | ▼ Sell | Tax Withholding | 1,233 | $10K | 3/1/2025 |
| Yingli Ma | ▼ Sell | Tax Withholding | 1,824 | $14K | 3/1/2025 |
| Xichen Lin | ▼ Sell | Tax Withholding | 6,441 | $51K | 3/1/2025 |
| Jun Yoon | ▼ Sell | Tax Withholding | 5,940 | $47K | 3/1/2025 |
| Raymond C. Stevens | ▼ Sell | Tax Withholding | 12,495 | $99K | 3/1/2025 |
| Crespo Blas Coll | ▲ Buy | Grant | 90,600 | $0 | 9/18/2024 |
| Ashley Hall | ▲ Buy | Grant | 67,290 | $0 | 9/18/2024 |
| Raymond C. Stevens | ▲ Buy | Option Exercise | 99,999 | $39K | 6/12/2024 |
| Raymond C. Stevens | ▲ Buy | Option Exercise | 50,001 | $24K | 6/12/2024 |
| Raymond C. Stevens | ▼ Sell | Other | 555,000 | $0 | 6/10/2024 |
| Xichen Lin | ▲ Buy | Option Exercise | 106,200 | $36K | 6/3/2024 |
| Xichen Lin | ▼ Sell | Other | 106,200 | $0 | 6/3/2024 |
| Xichen Lin | ▲ Buy | Grant | 85,707 | $0 | 3/15/2024 |
| Yingli Ma | ▲ Buy | Grant | 36,729 | $0 | 3/15/2024 |
| Bach Mark Allen | ▲ Buy | Grant | 26,235 | $0 | 3/15/2024 |
| Jun Yoon | ▲ Buy | Grant | 59,469 | $0 | 3/15/2024 |
| Raymond C. Stevens | ▲ Buy | Grant | 134,682 | $0 | 3/15/2024 |
| BVF PARTNERS L P/IL | ▼ Sell | Other | 462,605 | — | 5/10/2023 |
| BVF PARTNERS L P/IL | ▼ Sell | Other | 2,929,660 | — | 5/10/2023 |
| BVF PARTNERS L P/IL | ▼ Sell | Other | 4,018,253 | — | 5/10/2023 |
| FMR LLC | ▼ Sell | Other | 10,154 | — | 2/7/2023 |
| Daniel G. Welch | ▼ Sell | Other | 123,508 | — | 2/7/2023 |
| FMR LLC | ▼ Sell | Other | 965,115 | — | 2/7/2023 |
| FMR LLC | ▼ Sell | Other | 7,411 | — | 2/7/2023 |
| FMR LLC | ▼ Sell | Other | 6,947 | — | 2/7/2023 |
| FMR LLC | ▼ Sell | Other | 3,572,022 | — | 2/7/2023 |
| FMR LLC | ▼ Sell | Other | 568,098 | — | 2/7/2023 |
| FMR LLC | ▼ Sell | Other | 214,663 | — | 2/7/2023 |
| FIL Ltd | ▼ Sell | Other | 4,013,678 | — | 2/7/2023 |
| FIL Ltd | ▼ Sell | Other | 452,867 | — | 2/7/2023 |
| FIL Ltd | ▼ Sell | Other | 179,242 | — | 2/7/2023 |
| FIL Ltd | ▼ Sell | Other | 71,636 | — | 2/7/2023 |
| FIL Ltd | ▼ Sell | Other | 10,154 | — | 2/7/2023 |
| FIL Ltd | ▼ Sell | Other | 494,035 | — | 2/7/2023 |
| FIL Ltd | ▼ Sell | Other | 624,239 | — | 2/7/2023 |
| FIL Ltd | ▼ Sell | Other | 620,499 | — | 2/7/2023 |
| FIL Ltd | ▼ Sell | Other | 7,411 | — | 2/7/2023 |
| Ramy Farid | ▼ Sell | Other | 642,245 | — | 2/7/2023 |
| FMR LLC | ▼ Sell | Other | 414,621 | — | 2/7/2023 |
| FMR LLC | ▼ Sell | Other | 57,523 | — | 2/7/2023 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 11, 2026
LLY Stock Dip News Unrelated to GPCR
Recent headlines focus on Eli Lilly (LLY) stock performance, which does not provide specific news about Structure Therapeutics (GPCR). While GPCR technical indicators show extreme oversold conditions, the provided news articles do not contain company-specific updates or developments for this symbol.
LLY Stock Dip News Unrelated to GPCR. Recent headlines focus on Eli Lilly (LLY) stock performance, which does not provide specific news about Structure Therapeutics (GPCR). While GPCR technical indicators show extreme oversold conditions, the provided news articles do not contain company-specific updates or developments for this symbol.